| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,209 | 3,519 | 3,592 | 4,605 | | Cost of Revenue | 2,909 | 1,895 | 2,141 | 3,806 | | | Gross Profit | 1,300 | 1,624 | 1,451 | 799 | | | Operating Expenses | | Research Development | 349 | 301 | 247 | 207 | | Selling General and Administrative | 1,341 | 1,357 | 1,588 | 1,912 | | Non Recurring |
-
|
-
|
-
| 132 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (390) | (34) | (384) | (1,452) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,489 | 5,708 | (96) | (430) | | Earnings Before Interest And Taxes | 2,099 | 5,674 | (480) | (1,541) | | Interest Expense | 1,055 | 1,415 | 2,290 | 2,432 | | Income Before Tax | 1,044 | 4,259 | (2,770) | (3,973) | | Income Tax Expense | 75 | 45 |
-
|
-
| | Minority Interest | 39 | 51 | (31) | (80) | | | | Net Income From Continuing Ops | (463) | 4,265 | (2,801) | (4,394) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,008 | 4,265 | (2,801) | (4,394) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,008 | $4,265 | ($2,801) | ($4,394) |
|
1.52% Nasdaq 0.00%
Income Statement
